Soy protein isolate enhances hepatic copper accumulation and cell damage in LEC rats.
In a series of experiments, the effects of soy protein isolate (SPI), defatted soy (DFS) or SPI supplemented with L-methionine (SPIM) were examined in the Long-Evans rat with a cinnamon coat color (LEC rat), a model animal of Wilson's disease with a hereditary defect in the Atp7b gene resulting in defective copper metabolism and copper accumulation in hepatocytes. Milk casein in the control AIN-93G diet (20 g/100 g) was totally or 60% replaced by the soy products, SPI, DFS or SPIM (L-Met added to be equal to that in the control diet) beginning when rats were 6 wk old. Copper and iron concentrations in SPI and DFS were measured and the concentrations of these metals in the salt mix were adjusted so that test and the control diets had the same final concentrations. Food intake did not differ among groups. Rats were euthanized when they became moribund with jaundice. Survival time in the SPI diet group was shorter (14.0 +/- 0.8 wk) than in the control group (19.1 +/- 1.7 wk) (P < 0.001), and that in the DFS diet group was intermediate (16.0 +/- 1.7 wk). Survival time in the SPIM diet group did not differ from that of the SPI diet group. Copper concentrations in the livers of rats in the SPI and SPIM diet groups were approximately 80% higher than in rats fed the control diet. Liver iron concentrations did not differ among the groups. The results, including histological analyses, indicate that SPI enhances copper uptake into the liver cells and promotes liver cell damage in LEC rats. However, this did not occur in the livers of F344 rats with wild-type Atp7b. Recommendations to individuals suffering from Wilson's disease to avoid consuming soy protein may be warranted.
Yonezawa
Kayo
K
Department of Nutritional Science, Tokyo University of Agriculture, 1-1 Sakuragaoka 1, Setagaya, Tokyo 156-8502, USA.
Nunomiya
Sachiko
S
Daigo
Mitsue
M
Ogra
Yasumitsu
Y
Suzuki
Kazuo T
KT
Enomoto
Katsuhiko
K
Nakagama
Hitoshi
H
Yoshikawa
Kunie
K
Nagao
Minako
M
D000284:Administration, Oral; D000375:Aging / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003300:Copper / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D020318:Rats, Long-Evans; D011922:Rats, Mutant Strains; D030262:Soybean Proteins / Q000008:administration & dosage / Q000494:pharmacology*
D030262:Soybean Proteins; D003300:Copper